Retinoblastoma MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{Sahar}} {{Simrat}}
{{CMG}}; {{AE}} {{Sahar}} {{Simrat}}
==Overview==
==Overview==
On [[head]] and [[neck]] [[MRI]], retinoblastoma is characterized by isointense to hyperintense mass on T1-weighted MRI and hypointense mass on T2-weighted MRI.
On [[head]] and [[neck]] [[MRI]], retinoblastoma is characterized by hyperintense [[mass]] on T1-weighted [[MRI]] and hypointense [[mass]] on T2-weighted [[MRI]].
==MRI==
==MRI==
*MRI imaging study of retinoblastoma first introduced in 1980.<ref name="Schueler2003">{{cite journal|last1=Schueler|first1=A O|title=High resolution magnetic resonance imaging of retinoblastoma|journal=British Journal of Ophthalmology|volume=87|issue=3|year=2003|pages=330–335|issn=00071161|doi=10.1136/bjo.87.3.330}}</ref>
*[[Magnetic resonance imaging|MRI imaging study]] of retinoblastoma first introduced in 1980.<ref name="Schueler2003">{{cite journal|last1=Schueler|first1=A O|title=High resolution magnetic resonance imaging of retinoblastoma|journal=British Journal of Ophthalmology|volume=87|issue=3|year=2003|pages=330–335|issn=00071161|doi=10.1136/bjo.87.3.330}}</ref>
*This method is used as an extra diagnostic method to CT scan in suspected retinoblastoma cases especially in those whose CT scan imaging is doubtful for the presence of extra-ocular extension.<ref name="pmid22988349">{{cite journal |vauthors=Meel R, Radhakrishnan V, Bakhshi S |title=Current therapy and recent advances in the management of retinoblastoma |journal=Indian J Med Paediatr Oncol |volume=33 |issue=2 |pages=80–8 |date=April 2012 |pmid=22988349 |pmc=3439795 |doi=10.4103/0971-5851.99731 |url=}}</ref>
*This method is used as an extra [[diagnostic]] method to [[CT scan]] in suspected retinoblastoma cases especially in those whose [[CT scan|CT scan imaging]] is doubtful for the presence of extra-[[ocular]] extension.<ref name="pmid22988349">{{cite journal |vauthors=Meel R, Radhakrishnan V, Bakhshi S |title=Current therapy and recent advances in the management of retinoblastoma |journal=Indian J Med Paediatr Oncol |volume=33 |issue=2 |pages=80–8 |date=April 2012 |pmid=22988349 |pmc=3439795 |doi=10.4103/0971-5851.99731 |url=}}</ref>
*MRI diagnostic value in the diagnosis of advanced retinoblastoma is greater than CT scan.<ref name="de Jongde Graaf2014">{{cite journal|last1=de Jong|first1=Marcus C.|last2=de Graaf|first2=Pim|last3=Noij|first3=Daniel P.|last4=Göricke|first4=Sophia|last5=Maeder|first5=Philippe|last6=Galluzzi|first6=Paolo|last7=Brisse|first7=Hervé J.|last8=Moll|first8=Annette C.|last9=Castelijns|first9=Jonas A.|title=Diagnostic Performance of Magnetic Resonance Imaging and Computed Tomography for Advanced Retinoblastoma|journal=Ophthalmology|volume=121|issue=5|year=2014|pages=1109–1118|issn=01616420|doi=10.1016/j.ophtha.2013.11.021}}</ref>
*MRI diagnostic value in the [[diagnosis]] of advanced retinoblastoma is greater than [[CT scan]].<ref name="de Jongde Graaf2014">{{cite journal|last1=de Jong|first1=Marcus C.|last2=de Graaf|first2=Pim|last3=Noij|first3=Daniel P.|last4=Göricke|first4=Sophia|last5=Maeder|first5=Philippe|last6=Galluzzi|first6=Paolo|last7=Brisse|first7=Hervé J.|last8=Moll|first8=Annette C.|last9=Castelijns|first9=Jonas A.|title=Diagnostic Performance of Magnetic Resonance Imaging and Computed Tomography for Advanced Retinoblastoma|journal=Ophthalmology|volume=121|issue=5|year=2014|pages=1109–1118|issn=01616420|doi=10.1016/j.ophtha.2013.11.021}}</ref>
MRI findings diagnostic of retinoblastoma are:
[[MRI]] findings [[diagnostic]] of retinoblastoma are:
*On T1 image:Hyperintense mass compared to vitrous body
*On T1 image:Hyperintense mass compared to [[vitreous body]]
*On T2 image:Hypointense mass compared to vitrous body
*On T2 image:Hypointense mass compared to [[vitreous body]]
*It should be mentined that MRI is accurate for tumor staging and evaluation of metastatic risk factors.<ref name="de GraafBarkhof2005">{{cite journal|last1=de Graaf|first1=Pim|last2=Barkhof|first2=Frederik|last3=Moll|first3=Annette C.|last4=Imhof|first4=Saskia M.|last5=Knol|first5=Dirk L.|last6=van der Valk|first6=Paul|last7=Castelijns|first7=Jonas A.|title=Retinoblastoma: MR Imaging Parameters in Detection of Tumor Extent|journal=Radiology|volume=235|issue=1|year=2005|pages=197–207|issn=0033-8419|doi=10.1148/radiol.2351031301}}</ref>
*It should be mentioned that [[MRI]] is accurate for [[tumor]] staging and evaluation of [[metastatic]] [[risk factors]].<ref name="de GraafBarkhof2005">{{cite journal|last1=de Graaf|first1=Pim|last2=Barkhof|first2=Frederik|last3=Moll|first3=Annette C.|last4=Imhof|first4=Saskia M.|last5=Knol|first5=Dirk L.|last6=van der Valk|first6=Paul|last7=Castelijns|first7=Jonas A.|title=Retinoblastoma: MR Imaging Parameters in Detection of Tumor Extent|journal=Radiology|volume=235|issue=1|year=2005|pages=197–207|issn=0033-8419|doi=10.1148/radiol.2351031301}}</ref>
*This imaging study is capable to discreminate the tumor with secondary retinal detachment from  other causes of subretinal effusion or detachment, such as coat's disease, primary hyperplastic vitreous and retinopathy of prematurity.
*This [[Imaging studies|imaging study]] is capable to discriminate the [[tumor]] with secondary [[retinal detachment]] from  other [[causes]] of subretinal effusion or [[Retinal detachment|detachment]], such as coat's [[disease]], primary hyperplastic [[vitreous]] and [[retinopathy of prematurity]].
*Also, some expert argue that CT imaging studies in bilateral retinoblastoma individuals will increase the risk of individuals for future malignancies. MRI is not associated with such risk.
*Also, some expert argue that [[CT-scans|CT imaging studies]] in [[bilateral]] retinoblastoma individuals will increase the risk of individuals for future [[malignancies]]. [[MRI]] is not associated with such risk.
*MR imaging is the study of choice to rule out extra-ocualr extension of the tumor.<ref name="pmid22988349">{{cite journal |vauthors=Meel R, Radhakrishnan V, Bakhshi S |title=Current therapy and recent advances in the management of retinoblastoma |journal=Indian J Med Paediatr Oncol |volume=33 |issue=2 |pages=80–8 |date=April 2012 |pmid=22988349 |doi=10.4103/0971-5851.99731 |url=}}</ref>
*[[MRI|MR imaging]] is the study of choice to rule out extra-[[ocular]] extension of the [[tumor]].<ref name="pmid22988349">{{cite journal |vauthors=Meel R, Radhakrishnan V, Bakhshi S |title=Current therapy and recent advances in the management of retinoblastoma |journal=Indian J Med Paediatr Oncol |volume=33 |issue=2 |pages=80–8 |date=April 2012 |pmid=22988349 |doi=10.4103/0971-5851.99731 |url=}}</ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 16:59, 6 May 2019

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma MRI

CDC on Retinoblastoma MRI

Retinoblastoma MRI in the news

Blogs on Retinoblastoma MRI

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Simrat Sarai, M.D. [3]

Overview

On head and neck MRI, retinoblastoma is characterized by hyperintense mass on T1-weighted MRI and hypointense mass on T2-weighted MRI.

MRI

MRI findings diagnostic of retinoblastoma are:

References

  1. Schueler, A O (2003). "High resolution magnetic resonance imaging of retinoblastoma". British Journal of Ophthalmology. 87 (3): 330–335. doi:10.1136/bjo.87.3.330. ISSN 0007-1161.
  2. 2.0 2.1 Meel R, Radhakrishnan V, Bakhshi S (April 2012). "Current therapy and recent advances in the management of retinoblastoma". Indian J Med Paediatr Oncol. 33 (2): 80–8. doi:10.4103/0971-5851.99731. PMC 3439795. PMID 22988349.
  3. de Jong, Marcus C.; de Graaf, Pim; Noij, Daniel P.; Göricke, Sophia; Maeder, Philippe; Galluzzi, Paolo; Brisse, Hervé J.; Moll, Annette C.; Castelijns, Jonas A. (2014). "Diagnostic Performance of Magnetic Resonance Imaging and Computed Tomography for Advanced Retinoblastoma". Ophthalmology. 121 (5): 1109–1118. doi:10.1016/j.ophtha.2013.11.021. ISSN 0161-6420.
  4. de Graaf, Pim; Barkhof, Frederik; Moll, Annette C.; Imhof, Saskia M.; Knol, Dirk L.; van der Valk, Paul; Castelijns, Jonas A. (2005). "Retinoblastoma: MR Imaging Parameters in Detection of Tumor Extent". Radiology. 235 (1): 197–207. doi:10.1148/radiol.2351031301. ISSN 0033-8419.

Template:WikiDoc Sources